Inverse correlation between natural antitumor antibodies and tumor susceptibility in individual xid-bearing mice
- PMID: 2057021
Inverse correlation between natural antitumor antibodies and tumor susceptibility in individual xid-bearing mice
Abstract
Natural antibodies (NAb), natural killer (NK) cells and activated macrophages have all been implicated in the rejection of threshold syngeneic tumor inocula. Previous analysis of tumor susceptibility in normal versus inbred and F1 mice bearing the B cell deficiency associated with the xid mutation of CBA/N mice demonstrated an inverse relationship between the tumorigenicity of the RI-28, a radiation-induced leukemia of the CBA/H strain, and the pooled anti-RI-28 serum NAb levels in mice with the same genetic origins. No relationship with tumor susceptibility was seen with NK cell or in vivo activated macrophage cytolysis. Flow-cytometric determination of antitumor serum NAb bled from individual male and female (CBA/N X CBA/J)F1 mice 1 week prior to the threshold tumor inoculation has revealed extensive heterogeneity within the NAb levels of each sex. A comparative analysis of tumor fate with NAb activity revealed that tumors appeared in only 26.3% of animals with a mean fluorescence channel binding above 60 channels in contrast with 77.3% of animals with lower NAb levels. These data extend to the level of individual hosts the support for an inverse relationship between host NAb activity and tumor susceptibility. In addition, subsequent analysis of serum antitumor NAb levels, splenic NK cytolysis and in vitro lymphokine-activated macrophage activity with all three mediators originating from the same individual F1 mice showed no consistent correlations between these natural resistance activities, arguing for the exclusion of deficiencies in NK cell or macrophage function as the basis for the differential tumor susceptibility in individual F1 mice.
Similar articles
-
Low natural antibody and low in vivo tumor resistance, in xid-bearing B-cell deficient mice.J Immunol. 1989 May 15;142(10):3702-6. J Immunol. 1989. PMID: 2785560
-
Genetics, regulation, and specificity of murine natural antitumor antibodies and natural killer cells.J Natl Cancer Inst. 1981 Aug;67(2):445-53. J Natl Cancer Inst. 1981. PMID: 6943381
-
Tumor progression in vitro: the paradoxical natural antibody and complement-selected phenotype.Nat Immun Cell Growth Regul. 1987;6(4):189-204. Nat Immun Cell Growth Regul. 1987. PMID: 3683415
-
Human natural killer cell deficiencies and susceptibility to infection.Microbes Infect. 2002 Dec;4(15):1545-58. doi: 10.1016/s1286-4579(02)00038-2. Microbes Infect. 2002. PMID: 12505527 Review.
-
Are natural antibodies involved in tumour defence?Immunol Lett. 1999 Sep 1;69(3):317-20. doi: 10.1016/s0165-2478(99)00111-x. Immunol Lett. 1999. PMID: 10528795 Review.
Cited by
-
Tumour cell binding by a human monoclonal IgM antibody from the spleen of a non-tumour-associated patient is due to somatic mutations in the VH gene.Clin Exp Immunol. 1995 Mar;99(3):376-83. doi: 10.1111/j.1365-2249.1995.tb05561.x. Clin Exp Immunol. 1995. PMID: 7882560 Free PMC article.